Reported 2 months ago
Moderna's stock dropped sharply by 20% following the release of mixed second-quarter results, where the company reported revenues of $241 million but adjusted losses of $3.33 per share. CEO Stéphane Bancel emphasized a pullback from European governments due to budget constraints and ongoing economic difficulties, contributing to the company's decision to lower its full-year guidance.
Source: YAHOO